THE USE OF THE MARKOV PROCESS IN DESCRIBING THE NATURAL COURSE OF DIABETIC-RETINOPATHY

被引:14
作者
GARG, SK
MARSHALL, G
CHASE, HP
JACKSON, WE
ARCHER, P
CREWS, MJ
机构
[1] UNIV COLORADO,HLTH SCI CTR,BARBARA DAVIS CTR CHILDHOOD DIABET,DEPT PEDIAT,4200 E 9TH AVE,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,BARBARA DAVIS CTR CHILDHOOD DIABET,DEPT OPHTHALMOL,DENVER,CO 80262
[3] UNIV COLORADO,HLTH SCI CTR,BARBARA DAVIS CTR CHILDHOOD DIABET,DEPT PREVENT MED & BIOMETR,DENVER,CO 80262
关键词
D O I
10.1001/archopht.1990.01070110061025
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The natural course of early diabetic retinopathy in young subjects with insulin-dependent diabetes mellitus was evaluated during 693 patient visits for 259 subjects during a mean of 2.4 years. Diabetic retinopathy is considered a progressive disease among people with insulin-dependent diabetes mellitus (type I). Improvement of early retinopathy has not been recognized as a part of the natural course. In our experience, 25% of observations in subjects with early diabetic retinopathy (grades 2 and 3) showed improvement. Thus, 28 of 174 observations of diabetic retinopathy improved from grade 2 to grade 1, and 34 of 79 observations improved from grade 3 to grades 2 or 1. Markov chains indicate that 25% of observations of diabetic retinopathy will change from grade 1 to grade 5 or 6 in 17.0 years and 25% will change from grade 2 to grade 5 or 6 in 16.0 years. Future studies of diabetic retinopathy should consider a matrix of estimated transition probabilities, depending on the population, to judge probabilities of transition between states of retinopathy. © 1990, American Medical Association. All rights reserved.
引用
收藏
页码:1245 / 1247
页数:3
相关论文
共 22 条
[1]  
CHASE HP, 1990, OPHTHALMOLOGY, V97, P155
[2]   GLUCOSE CONTROL AND THE RENAL AND RETINAL COMPLICATIONS OF INSULIN-DEPENDENT DIABETES [J].
CHASE, HP ;
JACKSON, WE ;
HOOPS, SL ;
COCKERHAM, RS ;
ARCHER, PG ;
OBRIEN, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (08) :1155-1160
[3]   RISK-FACTORS AND MARKERS ASSOCIATED WITH PROLIFERATIVE RETINOPATHY IN PATIENTS WITH INSULIN-DEPENDENT DIABETES [J].
GROOP, LC ;
TEIR, H ;
KOSKIMIES, S ;
GROOP, PH ;
MATIKAINEN, E ;
VERKKALA, E ;
SCHEININ, T ;
KONTIAINEN, S ;
TEPPO, AM ;
TOLPPANEN, EM ;
TALLGREN, LG .
DIABETES, 1986, 35 (12) :1397-1403
[4]  
HOLMAN RR, 1983, LANCET, V1, P204
[5]   EFFECT OF MULTIPLE DAILY INSULIN INJECTIONS ON COURSE OF DIABETIC-RETINOPATHY [J].
JOB, D ;
ESCHWEGE, E ;
GUYOTARGENTON, C ;
AUBRY, JP ;
TCHOBROUTSKY, G .
DIABETES, 1976, 25 (05) :463-469
[7]  
KELLY TM, 1984, ARCH OPHTHALMOL-CHIC, V102, P1156
[8]  
KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P10
[9]   THE WISCONSIN EPIDEMIOLOGIC-STUDY OF DIABETIC-RETINOPATHY .9. 4-YEAR INCIDENCE AND PROGRESSION OF DIABETIC-RETINOPATHY WHEN AGE AT DIAGNOSIS IS LESS THAN 30 YEARS [J].
KLEIN, R ;
KLEIN, BEK ;
MOSS, SE ;
DAVIS, MD ;
DEMETS, DL .
ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (02) :237-243
[10]   GLYCOSYLATED HEMOGLOBIN PREDICTS THE INCIDENCE AND PROGRESSION OF DIABETIC-RETINOPATHY [J].
KLEIN, R ;
KLEIN, BEK ;
MOSS, SE ;
DAVIS, MD ;
DEMETS, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (19) :2864-2871